Showing results (1631-1640 of 1,683) with videos related to

Sort By:
Pageof 169
Allergologie Select|June 5, 2024
"Delabeling" by direct provocation testing in children and adolescents with a suspected history of a delayed reaction to β-lactam antibiotics: Consensus paper of Gesellschaft für pädiatrische Allergologie und Umweltmedizin (GPAU), Deutsche Gesellschaft für Allergologie und klinische Immunologie (DGAKI), and Ärzteverband deutscher Allergologen (ÄDA)Irena Neustädter, Sophie Blatt, Gerda Wurpts, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|June 2, 2018
Reverting the molecular fingerprint of tumor dormancy as a therapeutic strategy for glioblastomaGalia Tiram, Shiran Ferber, Paula Ofek, et al.
Structure (London, England : 1993)|February 6, 2026
Structural basis for pan-coronavirus inhibition of 3CL proteaseEswar R Reddem, Farhad Forouhar, Cheng Liu, et al.
The Journal of Investigative Dermatology|July 8, 2014
Der p 11 is a major allergen for house dust mite-allergic patients suffering from atopic dermatitisSrinita Banerjee, Yvonne Resch, Kuan-Wei Chen, et al.
Breast Cancer Research : BCR|December 28, 2019
Estrogen receptor coregulator binding modulator (ERX-11) enhances the activity of CDK4/6 inhibitors against estrogen receptor-positive breast cancersSuryavathi Viswanadhapalli, Shihong Ma, Gangadhara Reddy Sareddy, et al.
Journal of Viral Hepatitis|November 15, 2002
Characterization of nuclease-resistant ribozymes directed against hepatitis B virus RNAD V Morrissey, P A Lee, D A Johnson, et al.
Biofactors (Oxford, England)|December 10, 2015
Topical treatment with coenzyme Q10-containing formulas improves skin's Q10 level and provides antioxidative effectsAnja Knott, Volker Achterberg, Christoph Smuda, et al.
Biochemical and Biophysical Research Communications|April 4, 2021
ALG-097111, a potent and selective SARS-CoV-2 3-chymotrypsin-like cysteine protease inhibitor exhibits in vivo efficacy in a Syrian Hamster modelKoen Vandyck, Rana Abdelnabi, Kusum Gupta, et al.
Antiviral Therapy|May 4, 2005
Dynamic changes in clinical features and cytokine/chemokine responses in SARS patients treated with interferon alfacon-1 plus corticosteroidsSarah E Ward, Mona R Loutfy, Lawrence M Blatt, et al.
Nature Cancer|February 5, 2022
The current landscape of immunotherapy for pediatric brain tumorsEugene I Hwang, Elias J Sayour, Catherine T Flores, et al.
Pageof 169